Institutional Ownership Sc Pharmaceuticals Inc. (SCPH)
This table provides information about the institutional ownership of Sc Pharmaceuticals Inc. (SCPH). We have compiled data on the 117 institutions that hold shares in the stock, with a total of 38.3 Million shares, which have been reported (via 13F filing form) to have a value of $217 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Gabelli Funds LLC
Rye, NY |
Nov 12, 2025 Q3 2025 |
309,897
shares
|
$1.76 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Gabelli & CO Investment Advisers, Inc.
Rye, NY |
Nov 12, 2025 Q3 2025 |
307,800
shares
|
$1.75 Million
0.34% of portfolio
|
Q3 2025
New holding
|
|
|
Tejara Capital LTD
London, X0 |
Nov 04, 2025 Q3 2025 |
245,209
shares
|
$1.39 Million
0.73% of portfolio
|
Q3 2025
Reduced 50.73%
|
|
|
Groupe La Francaise
Paris, I0 |
Nov 13, 2025 Q3 2025 |
240,000
shares
|
$1.36 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Credit Industriel Et Commercial
Paris France, I0 |
Nov 07, 2025 Q3 2025 |
160,000
shares
|
$907,200
0.08% of portfolio
|
Q3 2025
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
157,217
shares
|
$891,420
0.0% of portfolio
|
Q3 2025
Added 20.87%
|
|
|
Deltec Asset Management LLC
|
Oct 24, 2025 Q3 2025 |
151,837
shares
|
$860,915
0.16% of portfolio
|
Q3 2025
New holding
|
|
|
Jbf Capital, Inc.
Aspen, CO |
Nov 14, 2025 Q3 2025 |
135,000
shares
|
$765,450
0.11% of portfolio
|
Q3 2025
Reduced 82.36%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
118,802
shares
|
$673,607
0.0% of portfolio
|
Q3 2025
Added 25.31%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
117,255
shares
|
$664,835
0.0% of portfolio
|
Q3 2025
Reduced 86.29%
|
|
|
Rice Hall James & Associates, LLC
|
Oct 16, 2025 Q3 2025 |
101,713
shares
|
$576,712
0.03% of portfolio
|
Q3 2025
Reduced 93.09%
|
|
|
Rangeley Capital, LLC
New Canaan, CT |
Nov 14, 2025 Q3 2025 |
93,747
shares
|
$531,545
0.46% of portfolio
|
Q3 2025
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
90,503
shares
|
$513,152
0.0% of portfolio
|
Q4 2024
Reduced 49.62%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
85,940
shares
|
$487,279
0.0% of portfolio
|
Q3 2025
Added 12.85%
|
|
|
Balanced Rock Investment Advisor
Roslindale, MA |
Nov 14, 2025 Q3 2025 |
83,133
shares
|
$471,364
0.34% of portfolio
|
Q3 2025
Reduced 8.61%
|
|
|
Raymond James & Associates
St Petersburg, FL |
Oct 18, 2024 Q3 2024 |
80,706
shares
|
$457,603
0.0% of portfolio
|
Q3 2024
Reduced 6.22%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
76,880
shares
|
$435,909
0.0% of portfolio
|
Q3 2025
Reduced 24.54%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Nov 14, 2025 Q3 2025 |
74,487
shares
|
$422,341
0.0% of portfolio
|
Q3 2025
Added 0.01%
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
65,062
shares
|
$368,901
0.02% of portfolio
|
Q3 2025
Added 104.88%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
61,084
shares
|
$346,346
0.0% of portfolio
|
Q3 2025
Reduced 7.73%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
54,641
shares
|
$309,814
0.0% of portfolio
|
Q3 2025
Added 0.26%
|
|
|
Quantinno Capital Management LP
New York, NY |
Nov 14, 2025 Q3 2025 |
38,728
shares
|
$219,587
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Thomasville National Bank
|
Oct 10, 2025 Q3 2025 |
37,500
shares
|
$212,625
0.01% of portfolio
|
Q2 2024
Added 1.9%
|
|
|
Trium Capital LLP
London, X0 |
Oct 16, 2025 Q3 2025 |
32,710
shares
|
$185,465
0.03% of portfolio
|
Q3 2025
New holding
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
31,528
shares
|
$178,763
0.0% of portfolio
|
Q3 2025
New holding
|
|